Literature DB >> 19020413

Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.

Martin Weber1, Wei-li Chang, Michelle Breier, David Ko, Neal R Swerdlow.   

Abstract

Prepulse inhibition (PPI) of the startle reflex is an operational measure of sensorimotor gating that is deficient in several brain disorders and is disrupted in rats by dopamine (DA) agonists. Robust heritable strain differences are observed between Sprague-Dawley (SD) and Long-Evans (LE) strains in sensitivity to the PPI-disruptive effects of DA agonists associated with differential gene expression in the nucleus accumbens. Here, we compared the contribution of D2 versus D3 receptors with this heritable difference, using the D3-preferential agonist (pramipexole), the mixed D3/D2 agonist (quinpirole), the mixed D1/D2-like agonist (apomorphine), and the preferential D2 antagonist (L741,626). All DA agonists disrupted PPI in SD and LE rats. Greater sensitivity for this effect was evident with apomorphine and quinpirole in SD than LE rats, but not with pramipexole. The selective D2 antagonist L741,626 preferentially reversed apomorphine-induced PPI deficits at a dose that did not alter pramipexole-induced PPI deficits. We conclude that the heritable pattern of greater PPI 'disruptability' by DA agonists in SD versus LE rats reflects differences in D2 but not D3 receptor-associated mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020413      PMCID: PMC3255557          DOI: 10.1097/FBP.0b013e32831c3b2b

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  41 in total

1.  Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathways.

Authors:  Paul D Shilling; Richard L Saint Marie; Jody M Shoemaker; Neal R Swerdlow
Journal:  Biol Psychiatry       Date:  2008-02-20       Impact factor: 13.382

2.  The novel antagonist, S33084, and GR218,231 interact selectively with cloned and native, rat dopamine D(3) receptors as compared with native, rat dopamine D(2) receptors.

Authors:  D Cussac; A Newman-Tancredi; L Sezgin; M J Millan
Journal:  Eur J Pharmacol       Date:  2000-04-07       Impact factor: 4.432

Review 3.  Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.

Authors:  M A Geyer; K Krebs-Thomson; D L Braff; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 4.  Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges.

Authors:  N R Swerdlow; M A Geyer; D L Braff
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 5.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

6.  Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits.

Authors:  K S Cadenhead; N R Swerdlow; K M Shafer; M Diaz; D L Braff
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

7.  S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

Authors:  M J Millan; A Gobert; A Newman-Tancredi; F Lejeune; D Cussac; J M Rivet; V Audinot; T Dubuffet; G Lavielle
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

8.  Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants.

Authors:  N R Swerdlow; A Platten; Y K Kim; I Gaudet; J Shoemaker; L Pitcher; P Auerbach
Journal:  Pharmacol Biochem Behav       Date:  2001 Oct-Nov       Impact factor: 3.533

9.  Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.

Authors:  Min Zhang; Michael E Ballard; Liliane V Unger; Andreas Haupt; Gerhard Gross; Michael W Decker; Karla U Drescher; Lynne E Rueter
Journal:  Behav Brain Res       Date:  2007-05-01       Impact factor: 3.332

10.  Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.

Authors:  Gregory T Collins; Amy Hauck Newman; Peter Grundt; Kenner C Rice; Stephen M Husbands; Cédric Chauvignac; Jianyong Chen; Shaomeng Wang; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2007-03-29       Impact factor: 4.530

View more
  16 in total

1.  The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats.

Authors:  Martin Weber; Wei-Li Chang; Michelle R Breier; Alex Yang; Mark J Millan; Neal R Swerdlow
Journal:  Eur Neuropsychopharmacol       Date:  2010-03-25       Impact factor: 4.600

Review 2.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

3.  Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.

Authors:  Martin Weber; Wei-Li Chang; John P Durbin; Paula E Park; Robert R Luedtke; Robert H Mach; Neal R Swerdlow
Journal:  Pharmacol Biochem Behav       Date:  2009-05-06       Impact factor: 3.533

4.  Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists.

Authors:  Aude Burban; Chit Sadakhom; Dominique Dumoulin; Christiane Rose; Gwenaëlle Le Pen; Henriette Frances; Jean-Michel Arrang
Journal:  Psychopharmacology (Berl)       Date:  2010-05-01       Impact factor: 4.530

5.  Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats.

Authors:  Wei-li Chang; Neal R Swerdlow; Michelle R Breier; Niveditha Thangaraj; Martin Weber
Journal:  Pharmacol Biochem Behav       Date:  2010-04-10       Impact factor: 3.533

6.  The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice.

Authors:  Wei-Li Chang; Mark A Geyer; Mahalah R Buell; Martin Weber; Neal R Swerdlow
Journal:  Behav Pharmacol       Date:  2010-03       Impact factor: 2.293

7.  The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.

Authors:  Hugo A Tejeda; Vladimir I Chefer; Agustin Zapata; Toni S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

8.  Amphetamine effects on startle gating in normal women and female rats.

Authors:  Jo A Talledo; Ashley N Sutherland Owens; Tijmen Schortinghuis; Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2009-01-16       Impact factor: 4.530

9.  Prepulse inhibition and genetic mouse models of schizophrenia.

Authors:  Susan B Powell; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2009-05-04       Impact factor: 3.332

10.  Pramipexole effects on startle gating in rats and normal men.

Authors:  Neal R Swerdlow; Sophia A Lelham; Ashley N Sutherland Owens; Wei-Li Chang; Sebastiaan D T Sassen; Jo A Talledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.